NPJ precision oncology

Precision cancer therapy is impacted by oncogene-dependent epigenome remodeling -- Live-single-cell phenotypic cancer biomarkers-future role in precision oncology? -- Precision oncology- the future of personalized cancer medicine? -- Circulating tumor cells: quintessential precision oncology presenting challenges for biology -- Resistance is futile: overcoming resistance to targeted therapies in lung adenocarcinoma -- EBV based cancer prevention and therapy in nasopharyngeal carcinoma -- Endothelial cell malignancies: new insights from the laboratory and clinic -- Revisiting the IGF-1R as a breast cancer target -- Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic -- Targeting the duality of cancer -- Network-based machine learning and graph theory algorithms for precision oncology -- Immune cell profiling in cancer: molecular approaches to cell-specific identification -- Addressing the challenges of applying precision oncology -- Precision histology: how deep learning is poised to revitalize histomorphology for personalized cancer care -- Towards personalized tumor markers -- Erratum: Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism.